Amgen Ventures Backs Syapse In $30M Precision Oncology Funding
socalTECH
NOVEMBER 17, 2017
Amgen Ventures , the venture investment arm of Thousand Oaks-based Amgen , is one of the new investors in precision oncology and medicine startup Syapse.
113 
Bryant Stibel's Kobe Bryant Dies In Helicopter Crash
socalTECH
JANUARY 27, 2020
Kobe Bryant , the basketball legend who also was one half of Los Angeles private equity investment firm Bryant Stibel , is dead at the age of 41, after a tragic helicopter crash in Calabasas took his life, the life of one of his daughters, and seven others.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Amgen Backs Tizona Therapeutics In $43M Funding
socalTECH
MARCH 8, 2016
Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners.
Akriveia Therapeutics Raises $7.5M
socalTECH
OCTOBER 12, 2016
Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M in a Series A investment. The investment came from F-Prime Capital Partners.
Amgen's Kevin Sharer Joins Healthcare Venture Capital Firm
socalTECH
MARCH 4, 2013
It might be, on news that Kevin Sharer , the former CEO of Thousand Oaks-based Amgen , has joined venture capital investment firm Foundation Medical Partners. Sharer had been Chairman and CEO from 2000 through 2012, and has been President and COO from 1992 to 2000. READ MORE>>.
Atara Biotherapeutics Gets $38.5M
socalTECH
DECEMBER 17, 2013
Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M The funding came from Amgen Ventures, Celgene Corporation, EcoR1 Capital, plus Alexandria Venture Investments, DAG Ventures, Domain Associates, and Kleiner Perkins Caufield & Byers.
Amgen Gets Exit At Adheron Therapeutics
socalTECH
OCTOBER 9, 2015
Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning.
Let's personalize your content